Table 2.
Two way comparisons of adolescent vaccination between study arms.
| Outcome | Comparison Arms | Odds Ratio, 95% CI |
|---|---|---|
| Young Adults | ||
| Got Any Dose of HPV During Study | Tailored vs. Usual Care | 2.3 (0.6, 8.3) |
| Untailored vs. Usual Care | 2.4 (0.7, 8.9) | |
| Tailored vs. Untailored | 0.9 (0.3, 2.6) | |
| Initiated the Vaccine Seriesb | Tailored vs. Usual Care | 2.3 (0.6, 8.8) |
| Untailored vs. Usual Care | 1.00 (0.2, 4.6) | |
| Tailored vs. Untailored | 2.3 (0.6, 8.6) | |
| Initiated the Vaccine, Series not Completedc | Tailored vs. Usual Care | 5.8 (0.3, 112.8) |
| Untailored vs. Usual Care | 12.4 (0.2, 722.4) | |
| Tailored vs. Untailored | 0.5 (0.0, 22.4) | |
| Completed the Vaccine Series, Among All Eligibled | Tailored vs. Usual Care | 0.7 (0.1, 5.3) |
| Untailored vs. Usual Care | 1.7 (0.3, 8.3) | |
| Tailored vs. Untailored | 0.4 (0.1, 2.6) | |
| Completed the Vaccine Series Among Those Already Initiated at Study Starte | Tailored vs. Usual Care | 1.1 (0.0, 60.2) |
| Untailored vs. Usual Care | 9.3 (0.5, 193.9) | |
| Tailored vs. Untailored | 0.1 (0.0, 2.4) | |
| Completed the Vaccine Series, Among Those Who Initiated During the Studyf | Tailored vs. Usual Care | 0.2 (0.0, 3.4) |
| Untailored vs. Usual Care | 0.1 (0.0, 4.7) | |
| Tailored v. Untailored | 2.2 (0.0, 103.5) | |
| Adolescents | ||
| Got Any Dose of HPV During Study | Tailored vs. Usual Care | 1.05 (0.7, 1.5) |
| Untailored vs. Usual Care | 1.1 (0.7, 1.7) | |
| Tailored vs. Untailored | 0.9 (0.7, 1.3) | |
| Initiated the Vaccine Seriesb | Tailored vs. Usual Care | 1.2 (0.7, 2.0) |
| Untailored vs. Usual Care | 1.3 (0.7, 2.2) | |
| Tailored vs. Untailored | 0.9 (0.5, 1.5) | |
| Initiated the Vaccine, Series not Completedc | Tailored vs. Usual Care | 1.3 (0.4, 4.1) |
| Untailored vs. Usual Care | 2.3 (0.7, 7.3) | |
| Tailored vs. Untailored | 0.6 (0.2, 1.8) | |
| Completed the Vaccine Series, Among All Eligibled | Tailored vs. Usual Care | 1.2 (0.7, 2.1) |
| Untailored vs. Usual Care | 0.8 (0.5, 1.5) | |
| Tailored vs. Untailored | 1.5 (0.9, 2.5) | |
| Completed the Vaccine Series Among Those Already Initiated at Study Starte | Tailored vs. Usual Care | 1.6 (0.8, 3.2) |
| Untailored vs. Usual Care | 0.8 (0.4, 1.6) | |
| Tailored vs. Untailored | 2.0 (1.1, 3.8) | |
| Completed the Vaccine Series, Among Those Who Initiated During the Studyf | Tailored vs. Usual Care | 0.7 (0.2, 2.2) |
| Untailored vs. Usual Care | 0.4 (0.1, 1.4) | |
| Tailored vs. Untailored | 1.7 (0.6, 5.0) | |
aP-value for the % vaccinated among the two arms denoted
bDescribes those who had 0 doses at study enrollment and received at least one dose during the study period.
cDescribes those who enrolled in the study with 0 doses, had enough time in the study period after the most recent dose to complete the series, but did not complete the series during the study period.
dDescribes those who enrolled in the study with 0, 1 or 2 doses, had enough time in the study period after the most recent dose to complete the series, and completed the series during the study period.
eDescribes those who enrolled in the study with 1 or 2 doses, had enough time in the study period after the most recent dose to complete the series, and completed the series during the study period.
fDescribes those who enrolled in the study with 0 doses, had enough time in the study period after the most recent dose to complete the series, and completed the series during the study period.
Bolded p-values highlight significant results.